Allarity Therapeutics, Inc. (ALLR) Tops Q1 EPS by 763c

Allarity Therapeutics, Inc. (NASDAQ: ALLR) reported Q1 EPS of ($0.25), $7.63 better than the analyst estimate of ($7.88).

For earnings history and earnings-related data on Allarity Therapeutics, Inc. (ALLR) click here.

You May Also Be Interested In

• Bessent: We Make A Market Buying Older Bonds
• Intel (INTC) call put ratio 2.5 calls to 1 put with a focus on October 2 weekly calls as share price up 7.8%
• US consumers’ inflation outlook steady in August, Fed report shows